Tag: CBD-
Self-Medication With Cannabis Linked to Anxiety, Depression, Paranoia
Weekly THC units higher with initiation of cannabis for anxiety, for depression, or because family members were using it
Cannabis-Based Medical Products Aid Primary Insomnia
Findings seen in as little as one month of treatment through 18 months of treatment
Unfavorable Mental Health Outcomes Reported With THC Product Use
In studies not testing for therapeutic effect, high-concentration THC products had unfavorable links with psychosis, schizophrenia
Discontinuation of Medical Cannabis Common in Musculoskeletal Pain
Many patients discontinue medical cannabis within one year, with higher rates for older patients
People With Eating Disorders Report Success Self-Medicating With Non-Rx Drugs
Psychedelics and cannabis may offer treatment hope for eating disorder symptoms
Cannabis Use Disorder Linked to Increased Risk for Oral Cancer
Significantly increased risk for oral cancer seen in unadjusted and adjusted analyses
Only 36.8 Percent of Teens With Cannabis Use Disorder Complete Treatment
Black non-Hispanic teens less likely to complete treatment, while Hispanic, Asian, Native Hawaiian/Pacific Islander more likely than Whites
Cannabis Use Disorder May Up Risk of Benign Salivary Gland Tumors
Increased relative risks of benign major salivary gland tumors and parotid salivary gland tumors, which persist over time
Adding Anxiety as Qualifier for Medical Cannabis Increases Number of Certifications
After addition of anxiety as qualifying condition, 60.26 percent of certifications were for anxiety
Increased Liver Enzyme Levels Seen With Use of Cannabidiol in Adults
Cannabidiol within the range consumers are taking with unregulated products linked to increase in liver enzymes
